ReviewFrontiers in pharmacology2021

Harnessing the ECM Microenvironment to Ameliorate Mesenchymal Stromal Cell-Based Therapy in Chronic Lung Diseases.

Linda Elowsson Rendin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.